Epogen/procrit Medical Drug

Medical Drugs > Erythropoiesis-stimulating

Description

Epoetin alfa (rINN) (pronounced /É�Ë�poÊ�É¨tÉ¨n/) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen.

Adverse effects:

Epoetin alfa is well-tolerated. Common side effects include high blood pressure, headache, joint-pain and clotting at the injection site. Rare cases of stinging at the injection site, skin rash and flu-like symptoms (joint and muscle pain) have occurred within a few hours following administration. More serious side effects, including allergic reactions, seizures and thrombotic events (e.g., heart attacks, strokes, and pulmonary embolism ) rarely occur.

References

MedicineNet.com Epogen Package Insert